IP Verse

Antisense Design - EP2752488

The patent EP2752488 was granted to Roche on Feb 12, 2020. The application was originally filed on Nov 18, 2003 under application number EP14163184A. The patent is currently recorded with a legal status of "Revoked".

EP2752488

ROCHE
Application Number
EP14163184A
Filing Date
Nov 18, 2003
Status
Revoked
Sep 23, 2022
Grant Date
Feb 12, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

IONIS PHARMACEUTICALSNov 12, 2020CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO9839352
DESCRIPTIONWO9914226
OPPOSITIONEP1013661
OPPOSITIONEP1984381
OPPOSITIONEP2176280
OPPOSITIONWO2004046160
OPPOSITIONWO9914226
OTHEREP1984381
OTHERWO9914226
SEARCHEP1152009
SEARCHWO0056748
SEARCHWO0066604
SEARCHWO0125248
SEARCHWO0125478
SEARCHWO0148190

Non-Patent Literature (NPL) Citations (65) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- A. A KOSHKIN ET AL., J. AM. CHEM. SOC., (1998), vol. 120, pages 13252 - 53
DESCRIPTION- A. A. KOSHKLN ET AL., J. ORG. CHEM., (1998), vol. 63, page 2778
DESCRIPTION- ALAYADI; COREY, CURR. OPINION IN INVES. DRUGS., (2001), vol. 2, no. 4, pages 558 - 61
DESCRIPTION- ARZUMANOV ET AL., BIOCHEMISTRY, (2001), vol. 40, pages 14645 - 54
DESCRIPTION- BENNET; COWSET, BIOCHIM. BIOPHYS. ACTA, (1999), vol. 1489, pages 19 - 30
DESCRIPTION- BIJSTERBOSCH, M.K.; MANOHARAN, M.; RUMP, E.T.; DE VRUEH, R.L.; VAN VEGHEL, R.; TIVEL, K.L.; BIESSEN, E.A.; BENNETT, C.F.; COOK, P., "In vivo fate of phosphorothioate antisense oligodeoxynudeotides: predominant uptake by scavenger receptors on endothelial liver cells", NUCLEIC ACIDS RES., (1997), vol. 25, pages 3290 - 3296
DESCRIPTION- BRAASCH; COREY, BIOCHEMISTRY, (2002), vol. 41, no. 14, pages 4503 - 19
DESCRIPTION- BRAASCH; COREY, CHEM. & BIOL., (2000), vol. 55, pages 1 - 7
DESCRIPTION- CHILDS ET AL., PNAS, (2002), vol. 99, no. 17, pages 11091 - 96
DESCRIPTION- CHURCH; GILBERT, PNAS, vol. 81, pages 1991 - 1995
DESCRIPTION- COOK, NUCLEOSIDES & NUCLEOTIDES, (1999), vol. 18, no. 6, 7, pages 1141 - 62
DESCRIPTION- CRINELLI ET AL., NUCL. ACID. RES., (2002), vol. 30, no. 11, pages 2435 - 43
DESCRIPTION- CRINELLI ET AL., NUD. ADD. RES., (2002), vol. 30, no. 11, pages 2435 - 43
DESCRIPTION- CROOKE, BIOTECHNOL.GENET.ENG REV., (1998), vol. 15, pages 121 - 57
DESCRIPTION- ELAYADI ET AL., BIOCHEMISTRY, (2002), vol. 1, pages 9973 - 9981
DESCRIPTION- ELAYADI ET AL., BIOCHEMISTRY, (2002), vol. 41, pages 9973 - 9981
DESCRIPTION- FLUITER K; TEN ASBROEK AL; DE WISSEL MB; JAKOBS ME; WISSENBACH M; OLSSON H; OLSEN 0; OERUM H; BAAS F., NUCLEIC ACIDS RES, (20030201), vol. 31, no. 3, pages 953 - 962
DESCRIPTION- FLUITER K; TEN ASBROEK AL; VAN GROENIGEN M; NOOIJ M; AALDERS MC; BAAS F., CANCER RES, (20020401), vol. 62, no. 7, pages 2024 - 2028
DESCRIPTION- FREIER; ALTMANN, NUCL. ACID RES., (1997), vol. 25, pages 4429 - 43
DESCRIPTION- GRAHAM, MJ.; FRELER, S.M.; CROOKE, R.M.; ECKER, D.J.; MASLOVA, R.N.; LESNIK, E.A., "Tritium labeling of antisense oligonucleotides was carried out by exchange with tritiated water", NUCLEIC ACIDS RES., (1993), vol. 21, pages 3737 - 3743
DESCRIPTION- HAKANSSON; WENGEL, BIOORG MED CHEM LETT, (2001), vol. 11, no. 7, pages 935 - 938
DESCRIPTION- JACOBSEN ET AL., NUCL. ACID. RES., (2002), vol. 30, no. 19
DESCRIPTION- KUMAR ET AL., BIOORG, & MED. CHEM. LETT., (1998), vol. 8, pages 2219 - 2222
DESCRIPTION- KURRECK ET AL., NUCL. ACID. RES., (2002), vol. 30, no. 9, pages 1911 - 1918
DESCRIPTION- KURRECK ET AL., NUD. ACID. RES., (2002), vol. 30, no. 9, pages 1911 - 1918
DESCRIPTION- N. K. CHRISTENSEN ET AL., J. AM. CHEM. SOC., (1998), vol. 120, page 5458
DESCRIPTION- OBIKA ET AL., BIOORG. & MED. CHEM., (2001), vol. 9, pages 1001 - 11
DESCRIPTION- PETERSEN ET AL., J. AMER. CHEM. SOC., (2001), vol. 123, no. 30, pages 7431 - 32
DESCRIPTION- P. NIELSEN ET AL., CHEM. COMMUN., (1997), vol. 9, page 825
DESCRIPTION- P. NIELSEN ET AL., J. CHEM. SOC., PERKIN TRANS., (1997), vol. 1, page 3423
DESCRIPTION- RAJWANSHI ET AL., ANGEW. CHEM. INT. ED., (2000), vol. 39, pages 1656 - 1659
DESCRIPTION- RAJWANSHI ET AL., CHEM COMMUN., (1999), pages 1395 - 1396
DESCRIPTION- RAJWANSHI ET AL., CHEM. COMMUN., (1999), pages 2073 - 74
DESCRIPTION- RAJWANSHI ET AL., J. CHEM COMMUN., (1999), pages 2073 - 2074
DESCRIPTION- SHARPE ET AL., J.AM.SOC. NEPHROL., vol. 11, pages 1600 - 1606
DESCRIPTION- SIMEONOV; NIKIFOROV, NUCL. ACID. RES., (2002), vol. 30, no. 17
DESCRIPTION- SINGH ET AL., J. ORG. CHEM., (1998), vol. 63, pages 10035 - 39
DESCRIPTION- SINGH ET AL., J. ORG. CHERN., (1998), vol. 63, pages 10035 - 39
DESCRIPTION- SINGH, S. K., J. ORG. CHEM., (1998), vol. 63, pages 6078 - 79
DESCRIPTION- S. OBIKA ET AL., BIOORG. MED. CHEM. LETT., (1999), page 515
DESCRIPTION- SØRENSEN ET AL., AMER.CHEM. SOC., (2002), vol. 124, no. 10, pages 2164 - 76
DESCRIPTION- SORENSEN ET AL., J. AMER. CHEM. SOC., (2002), vol. 124, no. 10, pages 2164 - 76
DESCRIPTION- SØRENSEN ET AL., J.AMER.CHEM.SOC., (2002), vol. 124, no. 10, pages 2164 - 76
DESCRIPTION- TEN ASBROEK ET AL., NAR, vol. 28, pages 1133 - 1138
DESCRIPTION- VESTER ET AL., J. AMER. CHEM. SOC., (2002), vol. 124, no. 46, pages 13682 - 13683
DESCRIPTION- WAHLESTEDT ET AL., PNAS, (2000), vol. 97, no. 10, pages 5633 - 38
DESCRIPTION- WENGEL, J., Antisense Drug Technology; Principles, Strategies, and Applications, MARCEL DEKKER, INC., (2001), pages 339 - 357
DESCRIPTION- WENGEL, NUCLEOSIDES NUCLEOTIDES NUCLEIC ACIDS, (2001), vol. 20, no. 4-7, pages 389 - 396
DESCRIPTION- ZAMECNIK; STEPHENSON, PNAS, (1978), vol. 75, no. 1, pages 280 - 4
EXAMINATION- PALLAN P S ET AL, "Structure and nuclease resistance of 2',4'-constrained 2'-O-methoxyethyl (cMOE) and 2'-O-ethyl (cEt) modified DNAs", CHEMICAL COMMUNICATIONS 20120825 ROYAL SOCIETY OF CHEMISTRY GBR, (20120825), vol. 48, no. 66, ISSN 1359-7345, pages 8195 - 8197
EXAMINATION- KATRINE E. NIELSEN ET AL., "NMR studies of fully modified Locked Nucleic Acid (LNA) hybrids: solution structure of an LNA:RNA hybrid and characterization of an LNA:DNA hybrid", BIOCONJUGATE CHEMISTRY, (20040501), vol. 15, no. 3, doi:10.1021/bc034145h, ISSN 1043-1802, pages 449 - 457, XP055088565
EXAMINATION- JAKOB T. NIELSEN ET AL., "NMR structure of anx-L-LNA:RNA hybrid: structural implications for RNase H recognition", NUCLEIC ACIDS RESEARCH, INFORMATION RETRIEVAL LTD, GB, (20030101), vol. 31, no. 20, doi:10.1093/NAR/GKG800, ISSN 0305-1048, pages 5858 - 5867, XP002268963
OTHER- morita, k et al, "2'-O-4'-ethylene-brdiged nucleic acids ( ena): highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug", bioorganic & medicinal chemistry letters, vol. 12, (20020000), pages 73 - 76, XP055249515
OTHER- Sorensen, mads d et al, "alfa-L-ribo-configured locked nucleic acid ( alfa-L-LNA): synthesis and properties", journal American chemical society, vol. 124, no. 10, (20020214), page 2164, XP055249514
OTHER- kumar, r et al, "the first analogues of lna ( locked nucleic acids): phosphorothioate-LNA and 2'thio-LNA", bioorganic & medicinal chemistry letters, vol. 8, (19980000), pages 2219 - 2222, XP004137249
OTHER- Nielsen t et al, "NMR structure of anx-L-LNA:RNA hybrid: structural implications for RNase H recognition", Nucleic Acids Research, vol. 31, no. 20, ISSN 0305-1048, (20130101), pages 5858 - 5867, XP002268963
SEARCH- NIELSEN K.M.E. ET AL., "alpha-L-LNA (alpha-L-ribo configured locked nucleic acid) recognition of DNA: an NMR spectroscopic study", CHEMISTRY - A EUROPEAN JOURNAL, (20020702), vol. 8, no. 13, pages 3001 - 3009, XP002554919 [A] 1-15 * Duplex 1 in Scheme 2; page 3002, column R *
SEARCH- HAKANSSON A.E. ET AL., "The adenine derivative of alpha-l-LNA (alpha-l-ribo configured locked nucleic acid): synthesis and high-affinity hybridization towards DNA, RNA, LNA and alpha-l-LNA complementary sequences", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, (20010409), vol. 11, no. 7, doi:10.1016/S0960-894X(01)00110-X, ISSN 0960-894X, pages 935 - 938, XP004232528 [A] 1-15 * the whole document *
SEARCH- KEINICKE LISE ET AL., "alpha-L-RNA (alpha-L-ribo configured RNA): synthesis and RNA-selective hybridization of alpha-L-RNA/alpha-L-LNA chimera", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (20020225), vol. 12, no. 4, ISSN 0960-894X, pages 593 - 596, XP002281374 [A] 1-15 * the whole document *
SEARCH- KUMAR RAVINDRA ET AL., "The first analogues of LNA (locked nucleic acids): phosphorothioate-LNA and 2'-thio-LNA", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (19980818), vol. 8, no. 16, ISSN 0960-894X, pages 2219 - 2222, XP004137249 [AD] 1-15 * the whole document *
SEARCH- SORENSEN MADS D. ET AL., "alpha-L-ribo-configured locked nucleic acid (alpha-L-LNA): synthesis and properties", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (20020313), vol. 124, no. 10, ISSN 0002-7863, pages 2164 - 2176, XP002281373 [AD] 1-15 * alpha-L-LNA-1; page 2168; figure 3 * * the whole document *
SEARCH- SINGH S.K. ET AL., "Synthesis of 2'-amino-LNA: a novel conformationally restricted high-affinity oligonucleotide analogue with a handle", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, (1998), vol. 63, no. 26, ISSN 0022-3263, pages 10035 - 10039, XP002252481 [AD] 1-15 * the whole document *
SEARCH- RAJWANSHI V.K. ET AL., "High-affinity nucleic acid recognition using 'LNA' (locked nucleic acid, beta-D-ribo configured LNA), 'xylo-LNA' (beta-D-xylo configured LNA) or 'alpha-L-LNA' (alpha-L-ribo configured LNA)", CHEMICAL COMMUNICATIONS, (1999), pages 2073 - 2074, XP002554920 [A] 1-15 * page 2074; table 1 * * the whole document *
SEARCH- KURRECK JENS ET AL., "Design of antisense oligonucleotides stabilized by locked nucleic acids", NUCLEIC ACIDS RESEARCH, (20020501), vol. 30, no. 9, ISSN 0305-1048, pages 1911 - 1918, XP002281375 [A] 1-15 * the whole document *
SEARCH- FRIEDEN MIRIAM ET AL., "Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA", NUCLEIC ACIDS RESEARCH, (20031101), vol. 31, no. 21, pages 6365 - 6372, XP002281376 [AP] 1-15 * page 6367; table 1 * * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents